Stocktoria

Editas Medicine, Inc. EDIT

Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2016-02-03 · LEI

Editas Medicine, Inc. institutional holders

InvestorSharesValue% of company
BlackRock Finance, Inc.7,782,517$36.3M7.95%
RENAISSANCE TECHNOLOGIES LLC2,468,919$8.0M2.52%
D. E. Shaw & Co., Inc.1,901,002$6.2M1.94%
AQR CAPITAL MANAGEMENT LLC1,572,242$5.1M1.61%
TWO SIGMA INVESTMENTS, LP1,332,976$4.3M1.36%
MILLENNIUM MANAGEMENT LLC498,997$1.6M0.51%
CITADEL ADVISORS LLC455,661$1.5M0.47%
Point72 Asset Management, L.P.125,234$405,7580.13%

% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.